Jaime Masjuan Selected Research

Jaime Masjuan Research Topics

Disease

18	Stroke (Strokes) 05/2024 - 09/2008
12	Ischemic Stroke 05/2024 - 07/2011
8	Multiple Sclerosis 08/2023 - 02/2003
8	Atrial Fibrillation 01/2023 - 01/2012
7	Hemorrhage 12/2022 - 01/2014
6	Transient Ischemic Attack 01/2024 - 04/2012
5	Embolic Stroke 01/2024 - 10/2012
4	Brain Ischemia (Cerebral Ischemia) 12/2023 - 09/2021
4	Cerebral Hemorrhage 01/2021 - 01/2012
3	Ischemia 05/2023 - 09/2021
2	Hematoma 04/2024 - 10/2011
2	Infarction (Infarctions) 01/2024 - 06/2022
2	COVID-19 01/2023 - 04/2021
2	Inflammation (Inflammations) 10/2022 - 01/2022
2	Thrombosis (Thrombus) 01/2022 - 12/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2021 - 01/2021
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2018 - 08/2017
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 07/2014 - 02/2008
1	Brain Infarction 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Conversion Disorder (Astasia Abasia) 01/2023
1	Infections 12/2022
1	Macrophage Activation Syndrome 10/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2022
1	Chronic Progressive Multiple Sclerosis 01/2022
1	Embolism (Embolus) 01/2022
1	Heart Failure 01/2022
1	Myocardial Infarction 01/2022
1	Relapsing-Remitting Multiple Sclerosis 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Multiple System Atrophy 11/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2019
1	Corticobasal Degeneration 11/2019
1	Nervous System Diseases (Neurological Disorders) 07/2014
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 07/2014
1	Neurologic Manifestations (Neurological Manifestations) 02/2014
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2014
1	Hematuria 01/2014
1	Metrorrhagia (Spotting) 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Seizures (Absence Seizure) 09/2011
1	Rupture 09/2011
1	Neoplasms (Cancer) 01/2007

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 01/2024 - 01/2012
5	RivaroxabanIBA 01/2023 - 01/2019
4	Vitamin K FDA Link 12/2022 - 01/2017
4	Dabigatran FDA Link 01/2019 - 07/2011
3	Factor XIa (Coagulation Factor XIa)IBA 05/2024 - 01/2022
3	Eukaryotic Initiation Factor-4EIBA 05/2023 - 09/2021
3	Oligoclonal BandsIBA 01/2023 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2019
3	Warfarin (Coumadin)FDA LinkGeneric 08/2017 - 10/2012
3	AntibodiesIBA 07/2014 - 01/2007
3	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2012 - 09/2008
2	AntioxidantsIBA 12/2023 - 06/2022
2	Proteins (Proteins, Gene)FDA Link 05/2023 - 09/2021
2	COVID-19 VaccinesIBA 04/2023 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2021
2	Immunoglobulin G (IgG)IBA 12/2022 - 04/2005
2	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2012
2	Peptide Initiation Factors (Initiation Factor)IBA 02/2022 - 09/2021
2	Immunoglobulin M (IgM)IBA 01/2021 - 02/2003
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 01/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2008 - 01/2007
1	VaccinesIBA 08/2023
1	collapsin response mediator protein-2IBA 05/2023
1	Protein Isoforms (Isoforms)IBA 05/2023
1	Rituximab (Mabthera)FDA Link 12/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	Neuroprotective AgentsIBA 06/2022
1	nitronesIBA 06/2022
1	Oxygen (Dioxygen)IBA 06/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	ocrelizumabIBA 01/2022
1	SteroidsIBA 04/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021
1	Alemtuzumab (Campath)FDA Link 01/2021
1	PF-05230907IBA 01/2021
1	LipidsIBA 01/2020
1	Ramipril (Altace)FDA LinkGeneric 01/2020
1	Atorvastatin (Lipitor)FDA Link 01/2020
1	edoxabanIBA 08/2017
1	apixabanIBA 10/2012
1	Cytidine Diphosphate Choline (Citicoline)IBA 07/2012
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2012
1	Cocaine (Cocaine HCl)IBA 09/2011
1	A-factor (Streptomyces)IBA 08/2011

Therapy/Procedure

8	Therapeutics 05/2024 - 01/2012
4	Secondary Prevention 01/2022 - 10/2012
3	Thrombectomy 09/2018 - 02/2014
2	Craniotomy 04/2024 - 10/2011
2	Artificial Respiration (Mechanical Ventilation) 04/2021 - 01/2021
2	Thrombolytic Therapy 10/2012 - 04/2012
2	Treatment Delay 01/2012 - 01/2012
1	Intravenous Administration 06/2022
1	Aftercare (After-Treatment) 09/2018
1	Patient Care 01/2018
1	Decompressive Craniectomy 10/2011